Amal Ali Elkordy

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Venues

Pharmaceutics

Pathogens (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

University of Sunderland

University of Bradford (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Sunderland

United Kingdom

Reader in Pharmaceutics

Education History

University of Bradford

United Kingdom

PHD

Publications

Amerah Parveen, Amal Ali Elkordy
Brief Insights into mRNA Vaccines: Their Successful Production and Nanoformulation for Effective Response against COVID-19 and Their Potential Success for Influenza A and B. Pathogens (Basel, Switzerland) 13 (6) (2024)
Amerah Parveen, Amal Ali Elkordy
Brief Insights into mRNA Vaccines: Their Successful Production and Nanoformulation for Effective Response against COVID-19 and Their Potential Success for Influenza A and B. Pathogens (Basel, Switzerland) 13 (6) (2024)
Amerah Parveen, Amal Ali Elkordy
Brief Insights into mRNA Vaccines: Their Successful Production and Nanoformulation for Effective Response against COVID-19 and Their Potential Success for Influenza A and B. Pathogens (Basel, Switzerland) 13 (6) (2024)
Yaqeen Nadheer Al Badri, Cheng Shu Chaw, Amal Ali Elkordy
Insights into Asymmetric Liposomes as a Potential Intervention for Drug Delivery Including Pulmonary Nanotherapeutics. Pharmaceutics 15 (1) (2023)
Yaqeen Nadheer Al Badri, Cheng Shu Chaw, Amal Ali Elkordy
Insights into Asymmetric Liposomes as a Potential Intervention for Drug Delivery Including Pulmonary Nanotherapeutics. Pharmaceutics 15 (1) (2023)
Yaqeen Nadheer Al Badri, Cheng Shu Chaw, Amal Ali Elkordy
Insights into Asymmetric Liposomes as a Potential Intervention for Drug Delivery Including Pulmonary Nanotherapeutics. Pharmaceutics 15 (1) (2023)
Yaqeen Nadheer Al Badri, Cheng Shu Chaw, Amal Ali Elkordy
Insights into Asymmetric Liposomes as a Potential Intervention for Drug Delivery Including Pulmonary Nanotherapeutics. Pharmaceutics 15 (1) (2023)
Mohamed Ahmed Attia, Ebtessam Ahmed Essa, Toka Tarek Elebyary, Ahmed Mostafa Faheem, Amal Ali Elkordy
Brief on Recent Application of Liposomal Vaccines for Lower Respiratory Tract Viral Infections: From Influenza to COVID-19 Vaccines. Pharmaceuticals (Basel, Switzerland) 14 (11) (2021)
Li Key Yeo, Cheng Shu Chaw, Amal Ali Elkordy
The Effects of Hydration Parameters and Co-Surfactants on Methylene Blue-Loaded Niosomes Prepared by the Thin Film Hydration Method. Pharmaceuticals (Basel, Switzerland) 12 (2) (2019)
Li Key Yeo, Temidayo O B Olusanya, Cheng Shu Chaw, Amal Ali Elkordy
Brief Effect of a Small Hydrophobic Drug (Cinnarizine) on the Physicochemical Characterisation of Niosomes Produced by Thin-Film Hydration and Microfluidic Methods. Pharmaceutics 10 (4) (2018)
Temidayo O B Olusanya, Rita Rushdi Haj Ahmad, Daniel M Ibegbu, James R Smith, Amal Ali Elkordy
Liposomal Drug Delivery Systems and Anticancer Drugs. Molecules (Basel, Switzerland) 23 (4) (2018)
Ashraf Saleh, Kenneth McGarry, Cheng Shu Chaw, Amal Ali Elkordy
Feasibility of Using Gluconolactone, Trehalose and Hydroxy-Propyl Gamma Cyclodextrin to Enhance Bendroflumethiazide Dissolution Using Lyophilisation and Physical Mixing Techniques. Pharmaceutics 10 (1) (2018)

Amal Ali Elkordy.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Amal Ali Elkordy